Leukemia
Thirty-year analysis of cardiac neoplasms at autopsy reviewed
Published in Blood Weekly, August 18th, 2005
According to recent research from Canada, "Cardiac neoplasms are rare and the vast majority are metastatic in origin. Symptoms of cardiac neoplasms (primary or metastatic) usually appear late in the course of the disease and are often ignored because of the more severe effects of the primary malignant disorder or its therapy. Consequently, cardiac neoplasms, especially metastatic ones, are often not discovered until autopsy."
J. Butany and colleagues, University of Toronto, conducted their study "to assess the incidence of cardiac neoplasms at autopsy and to determine the sites...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2005-08-18)
More Articles from Blood Weekly
- Cryopreservation
Open-freezing system allows survival of cryopreserved ovarian tissue - Hemophilia
Gene therapy induces tolerance to factor VIII inhibitors - Stem Cell Research
HSC mobilization speeds renal function recovery independent of SC contribution - Stem Cell Research
Monocyte-derived Neohepatocytes developed for autologous cell therapy - Stem Cell Transplantation
Transplant of dHGF-cultured hepatocytes prolongs survival of acute liver failure - AIDS-Related Emphysema
AIDS-related emphysema partly due to direct alveolar macrophage HIV-1 infection - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
